Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 1, 2003, Pages 244-254

  Stuyver, Lieven J ^a   Whitaker, Tony ^a   McBrayer, Tamara R ^a   Hernandez Santiago, Brenda I ^a   Lostia, Stefania ^a   Tharnish, Phillip M ^a   Ramesh, Mangala ^a   Chu, Chung K ^a   Jordan, Robert ^a   Shi, Junxing ^a   Rachakonda, Suguna ^a   Watanabe, Kyoichi A ^a   Otto, Michael J ^a   Schinazi, Raymond F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEXTRO 4 N HYDROXYCYTIDINE; CYTIDINE; DRUG ANALOG; RECOMBINANT ALPHA2 INTERFERON; RIBONUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG; URIDINE; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BOVINE VIRAL DIARRHEA VIRUS; DOSE RESPONSE; DRUG STRUCTURE; FLAVIVIRUS; HEPATITIS C VIRUS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PRIORITY JOURNAL; THERMODYNAMICS; VIRUS CULTURE; VIRUS INHIBITION;

EID: 12244305605     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.1.244-254.2003     Document Type: Article

References (47)

1. Alt, M., S. Eisenhardt, M. Serwe, R. Renz, J. W. Engels, and W. H. Caselmann. 1999. Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation. Eur. J. Clin. Investig. 29:868-876.
2. Alter, M. J., D. Kruszon-Moran, O. V. Nainan, G. M. McQuillan, F. Gao, L. A. Moyer, R. A. Kaslow, and H. S. Margolis. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341:556-562.
3. Baginski, S. G., D. C. Pevear, M. Seipel, S. C. Sun, C. A. Benetatos, S. K. Chunduru, C. M. Rice, and M. S. Collett. 2000. Mechanism of action of a pestivirus antiviral compound. Proc. Natl. Acad. Sci. USA 97:7981-7986.
4. Bartenschlager, R., and V. Lohmann. 2000. Replication of hepatitis C virus. J. Gen. Virol. 81:1631-1648.
5. Belen'kii, M. S., and R. F. Schinazi. 1994. Multiple drug effect analysis with confidence interval. Antivir. Res. 25:1-11.
6. Blight, K. J., A. A. Kolykhalov, and C. M. Rice. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290:1972-1974.
7. Branza-Nichita, N., D. Durantel, S. Carrouée-Durantel, R. A. Dwek, and N. Zitzmann. 2001. Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers. J. Virol. 75:3527-3536.
8. Collett, M. S., D. K. Anderson, and E. Retzel. 1988. Comparisons of the pestivirus bovine viral diarrhea virus with members of the flaviviridae. J. Gen. Virol. 69:2637-2643.
9. Collier, J., and R. Chapman. 2001. Combination therapy with interferon-alpha and ribavirin for hepatitis C: practical treatment issues. BioDrugs 15:225-238.
10. Crotty, S., C. E. Cameron, and R. Andino. 2001. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. USA 98:6895-6900.
11. Crotty, S., D. Maag, J. J. Arnold, W. Zhong, J. Y. Lau, Z. Hong, R. Andino, and C. E. Cameron. 2000. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat. Med. 6:1375-1379.
12. de Serres, F. J., and H. E. Brockman. 1993. Comparison of the spectra of genetic damage in N4-hydroxycytidine-induced ad-3 mutations between nucleotide excision repair-proficient and -deficient heterokaryons of Neurospora crassa. Mutat. Res. 285:145-163.
13. Di Bisceglie, A. M., J. McHutchison, and C. M. Rice. 2002. New therapeutic strategies for hepatitis C. Hepatology 35:224-231.
14. Di Pierro, D., B. Tavazzi, C. F. Perno, M. Bartolini, E. Balestra, R. Calio, B. Giardina, and G. Lazzarino. 1995. An ion-pairing high-performance liquid chromatographic method for the direct simultaneous determination of nucleotides, deoxynucleotides, nicotinic coenzymes, oxypurines, nucleosides, and bases in perchloric acid cell extracts. Anal. Biochem. 231:407-412.
15. Felczak, K., A. Miazga, J. Poznanski, M. Bretner, T. Kulikowski, J. M. Dzik, B. Golos, Z. Zielinski, J. Ciesla, and W. Rode. 2000. 5-Substituted N(4)-hydroxy-2′-deoxycytidines and their 5′-monophosphates: synthesis, conformation, interaction with tumor thymidylate synthase, and in vitro antitumor activity. J. Med. Chem. 43:4647-4656.
16. Friebe, P., and R. Bartenschlager. 2002. Genetic analysis of sequences in the 3′ nontranslated region of hepatitis C virus that are important for RNA replication. J. Virol. 76:5326-5338.
17. Geiss, G. K., M. C. An, R. E. Bumgarner, E. Hammersmark, D. Cunning. ham, and M. G. Katze. 2001. Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events J. Virol. 75:4321-4331.
18. Guo, J. T., V. V. Bichko, and C. Seeger. 2001. Effect of alpha interferon on the hepatitis C virus replicon. J. Virol. 75:8516-8523.
19. Janion, C. 1978. The efficiency and extent of mutagenic activity of some new mutagens of base-analogue type. Mutat. Res. 56:225-234.
20. Janion, C. 1984. Some problems of mutagenesis induced by base analogues. Acta Biochim. Pol. 31:183-192.
21. Janion, C., and B. W. Glickman. 1980. N4-hydroxycytidine: a mutagen specific for AT to GC transitions. Mutat. Res. 72:43-47.
22. Jordan, R., O. V. Nikolaeva, L. Wang, B. Conyers, A. Mehta, R. A. Dwek, and T. M. Block. 2002. Inhibition of host ER glucosidase activity prevents golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions. Virology 295:10-19.
23. Kato-Maeda, M., Q. Gao, and P. M. Small. 2001. Microarray analysis of pathogens and their interaction with hosts. Cell. Microbiol. 3:713-719.
24. Kim, J. L., K. A. Morgenstern, J. P. Griffith, M. D. Dwyer, J. A. Thomson, M. A. Murcko, C. Lin, and P. R. Caron. 1998. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 6:89-100.
25. Krieger, N., V. Lohmann, and R. Bartenschlager. 2001. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J. Virol. 75:4614-4624.
26. Lee, P. A., L. M. Blatt, K. S. Blanchard, K. S. Bouhana, P. A. Pavco, L. Bellon, and J. A. Sandberg. 2000. Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration in mice. Hepatology 32:640-646.
27. Les, A., L. Adamowicz, and W. Rode. 1993. Structure and conformation of N4-hydroxycytosine and N4-hydroxy-5-fluorocytosine. A theoretical ab initio study. Biochim. Biophys. Acta 1173:39-48.
28. Lohmann, V., F. Korner, U. Herian, and R. Bartenschlager. 1997. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J. Virol. 71:8416-8428.
29. Lohmann, V., F. Korner, J. Koch, U. Herian, L. Theilmann, and R. Bartenschlager. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-113.
30. Luo, G., R. K. Hamatake, D. M. Mathis, J. Racela, K. L. Rigat, J. Lemm, and R. J. Colonno. 2000. De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus. J. Virol. 74:851-863.
31. Markland, W., T. J. McQuaid, J. Jain, and A. D. Kwong. 2000. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon. Antimicrob. Agents Chemother. 44:859-866.
32. Mendez, E., N. Ruggli, M. S. Collett, and C. M. Rice. 1998. Infectious bovine viral diarrhea virus (strain NADL) RNA from stable cDNA clones: a cellular insert determines NS3 production and viral cytopathogenicity. J. Virol. 72:4737-4745.
33. Nam, J. H., J. Bukh, R. H. Purcell, and S. U. Emerson. 2001. High-level expression of hepatitis C virus (HCV) structural proteins by a chimeric HCV/BVDV genome propagated as a BVDV pseudotype. J. Virol. Methods 97:113-123.
34. Narjes, F., M. Brunetti, S. Colarusso, B. Gerlach, U. Koch, G. Biasiol, D. Fattori, R. De Francesco, V. G. Matassa, and C. Steinkuhler. 2000. Alpha-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 protease. Biochemistry 39:1849-1861.
35. Negishi, K., C. Harada, Y, Ohara, K. Oohara, N. Nitta, and H. Hayatsu, 1983. N4-aminocytidine, a nucleoside analog that has an exceptionally high mutagenic activity. Nucleic Acids Res. 11:5223-5233.
36. Pallaoro, M., A. Lahm, G. Biasiol, M. Brunetti, C. Nardella, L. Orsatti, F. Bonelli, S. Orru, F. Narjes, and C. Steinkuhler. 2001. Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor protein. J. Virol. 75:9939-9946.
37. Pietschmann, T., V. Lohmann, G. Rutter, K. Kurpanek, and R. Bartenschlager. 2001. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J. Virol. 75:1252-1264.
38. Popowska, E., and C. Janion. 1975. The metabolism of N4-hydroxycytidine - a mutagen for Salmonella typhimurium. Nucleic Acids Res. 2:1143-1151.
39. Reigadas, S., M. Ventura, L. Sarih-Cottin, M. Castroviejo, S. Litvak, and T. Astier-Gin. 2001. HCV RNA-dependent RNA polymerase replicates in vitro the 3′ terminal region of the minus-strand viral RNA more efficiently than the 3′ terminal region of the plus RNA. Eur. J. Biochem. 268:5857-5867.
40. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
41. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
42. Schinazi, R. F., R. M. J. Lloyd, M. H. Nguyen, D. L. Cannon, A. McMillan, N. Ilksoy, C. K. Chu, D. C. Liotta, H. Z. Bazmi, and J. W. Mellors. 1993. Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. Antimicrob. Agents Chemother. 37:875-881.
43. Sidwell, R. W., J. H. Huffman, G. P. Khare, L. B. Allen, J. T. Witkowski, and R. K. Robins. 1972. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science 177:705-706.
44. Stuyver, L. J., S. Lostia, M. Adams, J. S. Mathew, B. S. Pai, J. P. Grier, P. M. Tharnish, Y. Choi, Y. Chong, H. Cho, C. K. Chu, M. J. Otto, and R. F. Schinazi. 2002. Antiviral activities and cellular toxicities of 2′,3′-dideoxy-2′,3′-didehydrocytidine analogues. Antimicrob. Agents Chemother. 46:3854-3860.
45. Sullivan, D. G., and R. K. Akkina. 1995. A nested polymerase chain reaction assay to differentiate pestiviruses. Virus Res. 38:231-239.
46. Willis, R. C., D. A. Carson, and J. E. Seegmiller. 1978. Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line. Proc. Natl. Acad. Sci. USA 75:3042-3044.
47. Zitzmann, N., A. S. Mehta, S. Carrouee, T. D. Butters, F. M. Platt, J. McCauley, B. S. Blumberg, R. A. Dwek, and T. M. Block. 1999. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc. Natl. Acad. Sci. USA 96:11878-11882.